<DOC>
	<DOCNO>NCT02864680</DOCNO>
	<brief_summary>This study evaluate impact regular use cannabis spatial sensitivity magnocellular system ( visual event-related potential , visual ERP ) . Secondary purpose study evaluate impact regular use cannabis temporal sensitivity magnocellular system ( visual event-related potential ) , dynamic cortical visual processing face perception test ( visual event-related potential ) function retinal photopic scotopic system ( electroretinogram ) . The ancillary study genetic analysis group candidate gene aim identify biomarkers change visual processing . This allow distinguish among homogeneous specific group future study large cannabis user population . This ancillary study concern participant subject informed consent ( facultative study ) .</brief_summary>
	<brief_title>Electrophysiological Study Functioning Magnocellular Visual Pathway Regular Cannabis Users</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Affiliation social security plan Normal visual acuity adjust normal normal dilate fundus examination Signature inform consent Cannabis user group : More 7 cannabis us per week previous month Cannabis user group : Positive urinary analysis presence cannabis Healthy , non user control group : Absence cannabis tobacco use last 12 month Healthy , non user control group : Negative urinary analysis presence cannabis Healthy , non user control group : Age sex match cannabis user group Healthy , tobacco user control group : Tobacco use least 12 month Healthy , tobacco user control group : Low strong addiction tobacco ( Fagerstr√∂m test ) Healthy , tobacco user control group : Absence cannabis use 12 month Healthy , tobacco user control group : Negative urinary analysis presence cannabis Healthy , tobacco user control group : Age sex match cannabis user group Schizophrenia patient control group : Schizophrenia accord DMS IV criterion ( MINI test ) Schizophrenia patient control group : Absence cannabis use one month ( regardless tobacco use ) Schizophrenia patient control group : Negative urinary analysis presence cannabis Schizophrenia patient control group : Age sex match cannabis user group Acute psychiatric pathology ( axis I DSM IV , measure MINI ) except anxiety disorder ( except schizophrenia group ) Deficiency subject make difficult impossible his/her participation study comprehension information Dyslexia Addiction alcohol accord AUDIT scale Abuse addiction substance accord DSM IV criterion Acute retinal disorder Chronic glaucoma Ophthalmic pathology affect visual acuity Current ocular infection Persons guardianship , curatorship judicial protection Pregnant breastfeed woman Persons lifeanddeath emergency Absence social security plan Results preliminary medical examination incompatible study Simultaneous participation another therapeutic interventional study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cannabis</keyword>
	<keyword>magnocellular pathway</keyword>
</DOC>